TILT Holdings (TLLTF) Income from Non-Controlling Interests (2022 - 2023)
TILT Holdings (TLLTF) reported Income from Non-Controlling Interests of -$1.4 million for Q2 2023, down 47966.67% on a YoY basis from N/an in Q2 2022, and down 16122.22% quarter-over-quarter from $9000.0 in Q1 2023.
TILT Holdings (TLLTF) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends
TILT Holdings has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$1.4 million in Q2 2023.
- For the quarter ending Q2 2023, Income from Non-Controlling Interests fell 47966.67% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2023 stood at -$1.4 million (down 15822.22% YoY), and the FY2023 full-year result was -$1.4 million, down 15822.22% from the prior year.
- Income from Non-Controlling Interests for Q2 2023 stood at -$1.4 million, down from $9000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $9000.0 in Q1 2023, with the low at -$1.4 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | TILT Holdings | - | - | 1.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.44 Mn |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | -5,000.00 |